Cannabis oil in treating Parkinson’s disease: improvement of motor and non-motor symptoms: a case report
Open Access
- 1 January 2024
- journal article
- case report
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 84, e290305
Abstract
Parkinson’s disease (PD) is characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta, which leads to a reduction in the production of dopamine. Medication with levodopa becomes less effective as the disease progresses. Despite the excellent results observed in clinical practice with the medicinal use of Cannabis in the treatment of PD, the level of scientific evidence is still limited due to the small number of studies published in this field. We present the case of a 77-year-old man diagnosed 22 years ago with PD in an advanced stage, with significant bradykinesia, tremor, and rigidity along with the inability to maintain an upright position and walk, exacerbated by a femur fracture. He also had advanced dysphagia, resulting in a gastrostomy. Although lucid, he showed no interest in conversation and tended to become depressed and isolated. He used Prolopa® with no satisfactory therapeutic response. After starting treatment with Cannabis sativa oil, he is now able to walk around the house frequently and eat pasty food regularly without choking or broncho-aspiration episodes. There has also been a significant improvement in non-motor symptoms; he is more active, cheerful, communicative, and attentive to his surroundings. Further studies are needed to elucidate these results and the mechanisms of action of cannabinoids through which they exert possible neuroprotective and neuroreparative effects. These compelling results suggest that cannabis oil may offer a valuable and effective therapeutic option for individuals with Parkinson's disease.Keywords
This publication has 11 references indexed in Scilit:
- A Case Report of Treatment-Resistant Agitation in Dementia With Lewy Bodies: Medical Marijuana as an Alternative to AntipsychoticsJournal of Palliative Medicine, 2023
- Challenges in the diagnosis of Parkinson's diseaseThe Lancet Neurology, 2021
- Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a ReviewMolecular Neurobiology, 2020
- Cannabinoids in the Treatment of Epilepsy: Current Status and Future ProspectsNeuropsychiatric Disease and Treatment, 2020
- Neurological Improvement with Medical Cannabis in a Progressive Supranuclear Palsy Patient: A Case ReportMedical Cannabis and Cannabinoids, 2019
- Motor and Nonmotor Complications of Levodopa: Phenomenology, Risk Factors, and Imaging FeaturesMovement Disorders, 2018
- The neuroprotection of cannabidiol against MPP + -induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson's diseaseToxicology in Vitro, 2015
- Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's diseaseJournal of the Neurological Sciences, 2013
- Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's diseaseNeuropathology and Applied Neurobiology, 2012
- Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson modelEuropean Neuropsychopharmacology, 2008